These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21880743)

  • 1. Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.
    Tandon R; SenGupta D; Ndhlovu LC; Vieira RG; Jones RB; York VA; Vieira VA; Sharp ER; Wiznia AA; Ostrowski MA; Rosenberg MG; Nixon DF
    J Virol; 2011 Nov; 85(21):11526-31. PubMed ID: 21880743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses to human endogenous retroviruses in HIV-1 infection.
    Garrison KE; Jones RB; Meiklejohn DA; Anwar N; Ndhlovu LC; Chapman JM; Erickson AL; Agrawal A; Spotts G; Hecht FM; Rakoff-Nahoum S; Lenz J; Ostrowski MA; Nixon DF
    PLoS Pathog; 2007 Nov; 3(11):e165. PubMed ID: 17997601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
    SenGupta D; Tandon R; Vieira RG; Ndhlovu LC; Lown-Hecht R; Ormsby CE; Loh L; Jones RB; Garrison KE; Martin JN; York VA; Spotts G; Reyes-Terán G; Ostrowski MA; Hecht FM; Deeks SG; Nixon DF
    J Virol; 2011 Jul; 85(14):6977-85. PubMed ID: 21525339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
    Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.
    Jones RB; John VM; Hunter DV; Martin E; Mujib S; Mihajlovic V; Burgers PC; Luider TM; Gyenes G; Sheppard NC; Sengupta D; Tandon R; Yue FY; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    Clin Vaccine Immunol; 2012 Feb; 19(2):288-92. PubMed ID: 22205657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Infection of Primary CD4
    Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human endogenous retrovirus K and W in babies.
    Nali LH; Oliveira AC; Alves DO; Caleiro GS; Nunes CF; Gerhardt D; Succi RC; Romano CM; Machado DM
    Arch Virol; 2017 Mar; 162(3):857-861. PubMed ID: 27885560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.
    Ormsby CE; Sengupta D; Tandon R; Deeks SG; Martin JN; Jones RB; Ostrowski MA; Garrison KE; Vázquez-Pérez JA; Reyes-Terán G; Nixon DF
    PLoS One; 2012; 7(8):e41021. PubMed ID: 22879884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection and HERV expression: a review.
    van der Kuyl AC
    Retrovirology; 2012 Jan; 9():6. PubMed ID: 22248111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1-positive patients.
    Stevens RW; Baltch AL; Smith RP; McCreedy BJ; Michelsen PB; Bopp LH; Urnovitz HB
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):783-6. PubMed ID: 10548563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma.
    Rakoff-Nahoum S; Kuebler PJ; Heymann JJ; E Sheehy M; Ortiz GM; S Ogg G; Barbour JD; Lenz J; Steinfeld AD; Nixon DF
    AIDS Res Hum Retroviruses; 2006 Jan; 22(1):52-6. PubMed ID: 16438646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro.
    Contreras-Galindo R; López P; Vélez R; Yamamura Y
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):116-22. PubMed ID: 17263641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
    Jones RB; Leal FE; Hasenkrug AM; Segurado AC; Nixon DF; Ostrowski MA; Kallas EG
    J Negat Results Biomed; 2013 Jan; 12():3. PubMed ID: 23305161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.
    Bhardwaj N; Maldarelli F; Mellors J; Coffin JM
    J Virol; 2014 Oct; 88(19):11108-20. PubMed ID: 25056891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1.
    Sharp ER; Barbour JD; Karlsson RK; Jordan KA; Sandberg JK; Wiznia A; Rosenberg MG; Nixon DF
    J Infect Dis; 2005 Nov; 192(10):1772-80. PubMed ID: 16235176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens.
    Contreras-Galindo R; González M; Almodovar-Camacho S; González-Ramírez S; Lorenzo E; Yamamura Y
    J Virol Methods; 2006 Sep; 136(1-2):51-7. PubMed ID: 16678919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects.
    Méndez-Lagares G; Díaz L; Correa-Rocha R; León Leal JA; Ferrando-Martínez S; Ruiz-Mateos E; Pozo-Balado MM; Gurbindo MD; de José MI; Muñoz-Fernández MA; Leal M; Pacheco YM
    Clin Microbiol Infect; 2013 Jun; 19(6):558-65. PubMed ID: 22735071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.
    Vincendeau M; Göttesdorfer I; Schreml JM; Wetie AG; Mayer J; Greenwood AD; Helfer M; Kramer S; Seifarth W; Hadian K; Brack-Werner R; Leib-Mösch C
    Retrovirology; 2015 Mar; 12():27. PubMed ID: 25886562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
    Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
    J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between HERV-K expression and HIV-1 viral load in plasma specimens.
    Esqueda D; Xu F; Moore Y; Yang Z; Huang G; Lennon PA; Hu PC; Dong J
    Ann Clin Lab Sci; 2013; 43(2):122-5. PubMed ID: 23694785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.